GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $322,000 | -28.6% | 8,000 | -30.8% | 0.02% | -29.0% |
| Q1 2018 | $451,000 | +10.0% | 11,555 | 0.0% | 0.03% | +14.8% |
| Q4 2017 | $410,000 | -12.6% | 11,555 | 0.0% | 0.03% | -18.2% |
| Q3 2017 | $469,000 | -5.8% | 11,555 | 0.0% | 0.03% | -8.3% |
| Q2 2017 | $498,000 | +2.3% | 11,555 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $487,000 | +9.4% | 11,555 | 0.0% | 0.04% | +2.9% |
| Q4 2016 | $445,000 | -10.6% | 11,555 | 0.0% | 0.04% | -14.6% |
| Q3 2016 | $498,000 | -0.6% | 11,555 | 0.0% | 0.04% | 0.0% |
| Q2 2016 | $501,000 | – | 11,555 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |